Streptococcus pneumoniae–the pneumococcus–affects children and adults worldwide.
Invasive pneumococcal disease, including pneumonia, meningitis and bacteraemia, has …

Clin Microbiol Infect 2012; 18 (Suppl. 5): 25–36 Abstract Pneumococcal conjugated
vaccines have been recommended in children for over a decade in many countries …

Individuals< 2 years and≥ 50 years of age, as well as those with other specific risk factors,
are especially vulnerable to invasive pneumococcal disease (IPD). Conjugate vaccines …

Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, and
acute otitis media in children and adults worldwide. In the age group of< 2 years the …

After heptavalent pneumococcal conjugate vaccine (PCV7) was marketed in France, Spain,
Belgium, and England and Wales (United Kingdom), invasive disease from non-PCV7 …

Globally, Streptococcus pneumoniae is a leading cause of invasive and noninvasive
disease in infants and young children. The emergence of antibiotic-resistant strains has …

In the Netherlands, the 7-valent pneumococcal conjugate vaccine (PCV-7) was
implemented in a 3+ 1-dose schedule in the national immunization program for infants born …

Background: Since the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7)
in the United States, the need for additional serotype coverage has become clear. Our …

BACKGROUND. Reliable epidemiologic surveillance of infectious diseases is important for
making rational choices for public health issues such as vaccination strategies. In Belgium …

Pneumococcal disease is a leading cause of childhood morbidity and mortality globally,
causing an estimated 0.7--1.0 million deaths annually among children aged< 5 years. A …